期刊档案 · Medicine-Orthopedics and Sports Medicine
Journal of Orthopaedic Translation
ISSN 2214-031X · eISSN 2214-0328 · Elsevier (Singapore) Pte Ltd · Singapore
Journal of Orthopaedic Translation 中科院 医学 1区（2025 年升级版，Top 期刊），影响因子 9.76，完全开放获取，APC 约 2,500 美元，近 24 个月 88 篇文章投稿到接收中位 143 天，2025 年发文 185 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Journal of Orthopaedic Translation 由 Elsevier (Singapore) Pte Ltd 出版，属中科院医学大类（2025 升级版1区，Top 期刊）。按 OpenAlex 近年发文统计，该刊主要发表 Osteoarthritis Treatment and Mechanisms、Bone Metabolism and Diseases、Bone health and osteoporosis research 等主题的论文，这 3 个主题约占 27.2%，主导子领域为 Orthopedics and Sports Medicine。（根据 OpenAlex 主题统计与中科院分区数据生成）
Official journal of CSOS and ICMRSThe Journal of Orthopaedic Translation (JOT) is the official peer-reviewed, open access journal of the Chinese Speaking Orthopaedic Society (CSOS) and the International Chinese Musculoskeletal Research Society (ICMRS). It is published bimonthly, in January, March, May, July, September and November, by Elsevier.The Journal focuses on the rapidly growing field of orthopaedic translational research. While there are a number of high quality orthopaedic journals, none are solely dedicated to the field of orthopaedic translational research. The importance of translational research is quickly being recognized by all spectrums of the scientific community, from clinicians to basic science researchers. To truly improve the health of people, scientific research on the cellular and molecular level must be utilized and applied appropriately in the clinical setting. A journal that is purely dedicated to the art of translational research is a monumental step in the advancement of musculoskeletal care by bringing cutting edge knowledge to the forefront and allowing pioneers of orthopaedic translation to exchange and mutually enhance expertise. JOT aims to be that linking factor and welcomes high quality manuscripts that will advance the field of orthopaedic translation.JOT is devoted to research and issues of strong interest in translational medicine on musculoskeletal and related themes. Material that are considered include any original research findings, discussions or analyses that will move the field closer to the goal of improving musculoskeletal health, diagnosis, prevention, and treatment of musculoskeletal disorders or injuries. Multidisciplinary approaches are particularly encouraged. We accept original research papers, review articles, editorials, perspectives, case reports and letters to the Editor.The main goal of JOT is to publish papers that identify and fill scientific knowledge gaps at the junction of basic research and clinical application (from bench to bedside) or community application (from bench to community). In this vein, original research should report significant progress toward the prevention, diagnosis, and treatment of musculoskeletal disorders and serve as templates for future exploration and investments in translational orthopaedics.Original papers are categorized into the following topics:Animal modelsBiomaterialsBiophysical stimulationClinical trialsDiagnosticsHealth promotionIndustries and marketsMedical devices and implantsNutrition and drugsRegenerative medicineRegulations and policiesRehabilitation
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Medicine-Orthopedics and Sports Medicine
主编 Regis O'Keefe出版商官网
编委会国家分布：中国大陆 221 位（约 67%）；主要国家 中国 221、中国香港 34、美国 30、澳大利亚 8、德国 7（共 329 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Osteoarthritis Treatment and MechanismsMedicine12.3%
- Bone Metabolism and DiseasesBiochemistry, Genetics and Molecular Biology7.8%
- Bone health and osteoporosis researchMedicine7.1%
- Bone Tissue Engineering MaterialsEngineering7%
- Spine and Intervertebral Disc PathologyMedicine6.4%
- Orthopaedic implants and arthroplastyMedicine6.2%
- Bone fractures and treatmentsMedicine4.9%
- Tendon Structure and TreatmentMedicine4.8%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 1 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 1 区 |
| 小类 | 骨科ORTHOPEDICS | 1 区 |
Top 期刊：是综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 1 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 1 区 |
| 小类 | 骨科ORTHOPEDICS | 1 区 |
Top 期刊：是综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 1 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 1 区 |
| 小类 | 骨科ORTHOPEDICS | 1 区 |
Top 期刊：是综述期刊：否
数据库收录
SCIEScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 9.76LetPub ·
- 影响因子（出版商公布）
- 9.8出版商官网 ·
- CiteScore 2026-06
- 14.5LetPub ·
- CiteScore（出版商公布）
- 14.5出版商官网 ·
- SJR 2026-06
- 1.94LetPub ·
- SNIP 2026-06
- 2.17LetPub ·
- h-index
- 15LetPub ·
- h-index
- 73OpenAlex ·
- i10-index
- 649OpenAlex ·
- 两年平均被引
- 7.47OpenAlex ·
- 自引率
- 5.1%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 156LetPub ·
逐年发文量 OpenAlex 统计 · 累计 1,491 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 174 | 174 | 146 |
| 2025 | 185 | 185 | 1,538 |
| 2024 | 118 | 118 | 1,877 |
| 2023 | 65 | 65 | 1,733 |
| 2022 | 117 | 117 | 3,634 |
| 2021 | 88 | 88 | 3,175 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
143 天投稿到接收中位数 · P25–P75 115 天 – 178 天
- 接收到上线
- 中位数 20 天（88 篇）
- 投稿到上线
- 中位数 164 天
- 样本
- 88 篇有投稿与接收日期的文章（窗口内共 375 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 18 WeeksLetPub ·
- 投稿到首次决定
- 7 天出版商官网 ·
- 外审后首次决定
- 50 天出版商官网 ·
- 投稿到接收
- 137 天出版商官网 ·
- 投稿到发表
- 77 天出版商官网 ·
- 投稿到发表（期刊自报）
- 约 26 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取DOAJ
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | USD 2,500 | 有 | CC BY、CC BY-NC-ND | |
| OpenAlex | USD 2,500 / EUR 2,340 / GBP 2,000 / JPY 310,080 | — | — | |
| LetPub | USD 2,000 | 有 | — | |
| 出版商官网 | USD 2,500 | — | — |
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点4 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- ≥ 1 个
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 不接收
- case reports and case series
接收的文章类型11 种，含篇幅限制
- editorials or articles published in the journal. Editorials should be no longer than 2000 words with no more than 50 references. Perspectives Perspectives正文 ≤ 2,000 词 · 参考文献 ≤ 50
- editorialsEditorials Editorials are short and invited opinion(s) that discuss an issue of immediate importance to the translational orthopaedic community.未说明篇幅
- letterve on the previously published article. Letters should be less than 1000 words, with no more than 10 references and 2 figures/tables. Lett正文 ≤ 1,000 词
- letters to the editorLetters provide readers with an opportunity to raise issues of interest to the translational medicine community or to respond to an article previously published…正文 ≤ 1,000 词 · 图表 ≤ 2 · 参考文献 ≤ 10
- original articleThese articles typically include randomized trials, intervention studies, studies of screening and diagnostic tests, laboratory and animal studies, cohort studi…图表 ≤ 10 · 参考文献 ≤ 80
- original articlesOriginal articles These articles typically include randomized trials, intervention studies, studies of screening and diagnostic tests, laboratory and animal stu…未说明篇幅
- perspectivetions of the research for patient care. Perspectives are limited to 5000 words (including abstract, main text, references and figure legen正文 ≤ 5,000 词 · 摘要 ≤ 100 词 · 图表 ≤ 4 · 参考文献 ≤ 50
- perspectivesPerspectives Perspectives discuss one or several papers recently published in the JOT or other journals that present key findings in translational research rele…未说明篇幅
- reviewfor ways to overcome these challenges. Reviews can be up to 10,000 words in length. They should have a short pithy title, an abstrac正文 ≤ 10,000 词
- review articleThese should provide a balanced synthesis of current knowledge on translational research in musculoskeletal and related themes. These articles have the specific…正文 ≤ 10,000 词 · 摘要 ≤ 500 词 · 图表 ≤ 8 · 参考文献 ≤ 200
- review articlesReview articles These should provide a balanced synthesis of current knowledge on translational research in musculoskeletal and related themes.未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
- AI 使用 Declaration of generative AI use
作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Group authorship
团体署名指将文章归属于一个明确且具名的作者群体，须在投稿时于标题页声明。 模型中文摘要
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
原文 ↗出版商官网 ·- 利益冲突 Declaration of competing interests
所有作者必须披露可能不当影响或偏颇其工作的与他人或组织的财务和个人关系。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
原文 ↗出版商官网 ·- 许可与版权 License options
作者将获得开放获取用户许可选项，建议在选择许可前审查这些选项及资助机构的许可要求。 模型中文摘要
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
原文 ↗出版商官网 ·- 开放获取 Open access
该期刊引导作者参阅其开放获取信息页面以了解开放获取选项。 模型中文摘要
We refer you to our open access information page to learn about open access options for this journal.
原文 ↗出版商官网 ·- 同行评审 Peer review
该期刊采用双盲同行评审流程，稿件通常至少由两名审稿人进行独立评审，录用与否由编辑决定。 模型中文摘要
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
原文 ↗出版商官网 ·- 预印本 Preprints
作者可按照Elsevier的文章共享政策分享预印本，分享预印本不计作先前发表。 模型中文摘要
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier (Singapore) Pte Ltd
- 出版国家或地区
- Singapore
- 出版语言
- English
- ISSN
- 2214-031X
- 电子版 ISSN
- 2214-0328
- 学会 / 主办单位
- CSOS and ICMRS
- 官方链接
- 期刊主页 ↗DOAJ
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Journal of Orthopaedic Translation 的常见问题
Journal of Orthopaedic Translation 是中科院几区期刊？
2025 年升级版分区表中，Journal of Orthopaedic Translation 为医学 1区，小类 骨科 1 区，属于 Top 期刊。2026 年新锐版分区表中为医学 1区。不同版本与大小类分区不能混用。
Journal of Orthopaedic Translation 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 9.76，CiteScore 为 14.5，h-index 为 73。
Journal of Orthopaedic Translation 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）88 篇已发表文章登记的日期，投稿到接收的中位数为 143 天（四分位 115–178 天）；投稿社区反馈的平均审稿速度为约 18 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Journal of Orthopaedic Translation 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：≥ 1 个；参考文献格式：顺序编码制（按引用顺序编号）。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Journal of Orthopaedic Translation 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 329 位编委中，中国大陆 221 位（约 67%）；人数最多的国家是 中国（221 位）、中国香港（34 位）、美国（30 位）。统计按编委会页面列出的机构国家计，仅供参考。
Journal of Orthopaedic Translation 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Journal of Orthopaedic Translation 被 SCIE、Scopus、DOAJ 收录。
Journal of Orthopaedic Translation 是开放获取期刊吗？版面费多少？
Journal of Orthopaedic Translation 为完全开放获取。APC 约 2,500 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。